This site is intended for UK Healthcare professionals only

This site is intended for UK healthcare professionals only

Menu

Resource Type: Recommended Reading
Therapy Area: General Women's Health

Bone-Forming Agent: A Consensus Advisory Statement

This statement, developed by the National Osteoporosis Guideline Group and Royal Osteoporosis Society, follows on from the NICE 2022 recommendations concerning the management of patients at high risk of fracture in the UK. 

Important information on who should be prioritised, the key warnings and precautions to be aware of and further considerations when prescribing Evenity®, an osteoporosis treatment, are covered.

Open here: Bone-Forming Agent: A Consensus Advisory Statement

Source: NOGG

5
Rate resource